By: Emily Matchar From: smithsonian.com Women eventually face the yearly ritual of the mammogram, usually suggested from age 50 onwards. It’s not painful, though notoriously uncomfortable, as two plates flatten the breasts, pancake-like, to get the best possible picture. The radiologist then looks at x-ray images for opaque spots that can indicate tumors. Mammography has been used since the late 1960s and is …
After Years of Decline, Researchers See Uptick in Size of Breast Cancer Tumors at Diagnosis
From: healthline.com Researchers say the size of breast tumors at diagnosis has decreased since routine screening came along, but they’re getting bigger. Breast tumors are significantly smaller at diagnosis today than they were in the early 1980s, thanks in large part to better screening.However, experts have changed screening guidelines in recent years to recommend younger women wait to start annual …
What Cancer Patients Should Know About Pharmaceutical Companies
View PostBreast cancer: Discovery of a protein linked to metastasis
Source: University of Montreal From: sciencedaily.com Jean-François Côté, a researcher at the Montreal Clinical Research Institute (IRCM) and professor at Université de Montréal’s Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, his team uncovered a protein that, once deactivated, could prevent the development of metastases in an aggressive type of cancer, HER2-positive breast cancer. One in eight …
Common drug may help battle aggressive breast cancer
By: Tim Newman From: medicalnewstoday.com Basal-like breast cancer affects women at a relatively young age and is challenging to treat. The discovery that a common drug for osteoporosis may halt its progress is welcome news. Basal-like breast cancer develops in younger women, and prognosis rates are the worst of any cancer type. Often caught at a late stage, the tumors are normally aggressive and …
New approach for hard-to-treat BRCA breast cancer shrinks tumours twice as fast
By: Henry Bodkin From: telegraph.co.uk Scientists have expressed optimism for women with hard-to-treat breast cancer after a new chemotherapy regime proved it can shrink tumours twice as fast as normal methods. Women with aggressive “triple-negative” disease fare much better on a non-standard chemotherapy drug if they have inherited BRCA gene mutations, the results of a trial showed. Currently most patients with this type of breast cancer, …
Study shows no increased risk of breast cancer recurrence after DIEP flap reconstruction
From: news-medical.net After surgery for breast cancer women who have undergone breast reconstruction using abdominal tissue do not have a higher risk of recurrence than women who have not undergone breast reconstruction. This has been shown by researchers at Karolinska Institutet in a study published in the British Journal of Surgery. In Sweden today, more than 90,000 women are living with a …
What Is Happening With Your Cancer Medical Information
View PostTargeted radiotherapy for breast cancer offers good quality of life and fewer side effects
Source: EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY (ESTRO) From: eurekalert.org Quality of life for women treated with a more targeted radiotherapy treatment – called accelerated partial breast irradiation – is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology [1]. The treatment uses …
Protein associated with aggressive breast cancer
Researchers at UT Southwestern Medical Center have identified a protein that is strongly associated with metastatic breast cancer and that could be a target for future therapies. High levels of the protein ZMYND8 are correlated with poor survival in breast cancer patients, said Dr. Weibo Luo, Assistant Professor of Pathology and Pharmacology, and with the Harold C. Simmons Comprehensive Cancer Center. Previous …